feed,title,long_url,short_url
BioRxiv,"Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2",https://biorxiv.org/cgi/content/short/2021.11.22.469117v1?rss=1,https://j.mp/3r6K5UO
